Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect-Reference-Cited by-同舟云学术

Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defect

Published:2022-11-01 Issue:21 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Zhou Haiyan^ORCID,Hong Ying,Scoto Mariacristina,Thomson Alison,Pead Emma,MacGillivray Tom^ORCID,Hernandez-Gerez Elena^ORCID,Catapano Francesco,Meng Jinhong^ORCID,Zhang Qiang,Hunter Gillian,Shorrock Hannah K.^ORCID,Ng Thomas K.,Hamida Abedallah,Sanson Mathilde^ORCID,Baranello Giovanni,Howell Kevin^ORCID,Gillingwater Thomas H.^ORCID,Brogan Paul,Thompson Dorothy A.^ORCID,Parson Simon H.^ORCID,Muntoni Francesco^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/153430/files/pdf

Reference87 articles.

1. Identification and characterization of a spinal muscular atrophy-determining gene

2. Ramblings in the history of spinal muscular atrophy

3. Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular Atrophy

4. Spinal muscular atrophy — insights and challenges in the treatment era

5. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy;Journal of Clinical Investigation;2024-05-09

2. From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA);Human Molecular Genetics;2024-05-04

3. Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment;PLOS Medicine;2024-04-04

4. 261st ENMC International Workshop: Management of safety issues arising following AAV gene therapy. 17th-19th June 2022, Hoofddorp, The Netherlands;Neuromuscular Disorders;2023-11

5. Necrotizing Enterocolitis following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series;The Journal of Pediatrics;2023-09